154 related articles for article (PubMed ID: 10837922)
1. N-myc and c-myc expression in Alzheimer disease, Huntington disease and Parkinson disease.
Ferrer I; Blanco R
Brain Res Mol Brain Res; 2000 May; 77(2):270-6. PubMed ID: 10837922
[TBL] [Abstract][Full Text] [Related]
2. Fas and Fas ligand expression in Alzheimer's disease.
Ferrer I; Puig B; Krupinsk J; Carmona M; Blanco R
Acta Neuropathol; 2001 Aug; 102(2):121-31. PubMed ID: 11563626
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of phosphorylated translation initiation factor 2 alpha in Alzheimer's disease and Creutzfeldt-Jakob's disease.
Ferrer I
Neuropathol Appl Neurobiol; 2002 Dec; 28(6):441-51. PubMed ID: 12445160
[TBL] [Abstract][Full Text] [Related]
4. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S
J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403
[TBL] [Abstract][Full Text] [Related]
5. Selective PrP-like protein, doppel immunoreactivity in dystrophic neurites of senile plaques in Alzheimer's disease.
Ferrer I; Freixas M; Blanco R; Carmona M; Puig B
Neuropathol Appl Neurobiol; 2004 Aug; 30(4):329-37. PubMed ID: 15305978
[TBL] [Abstract][Full Text] [Related]
6. Association of adipocyte enhancer-binding protein 1 with Alzheimer's disease pathology in human hippocampi.
Shijo M; Honda H; Suzuki SO; Hamasaki H; Hokama M; Abolhassani N; Nakabeppu Y; Ninomiya T; Kitazono T; Iwaki T
Brain Pathol; 2018 Jan; 28(1):58-71. PubMed ID: 27997051
[TBL] [Abstract][Full Text] [Related]
7. Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain.
Simpson JE; Ince PG; Lace G; Forster G; Shaw PJ; Matthews F; Savva G; Brayne C; Wharton SB;
Neurobiol Aging; 2010 Apr; 31(4):578-90. PubMed ID: 18586353
[TBL] [Abstract][Full Text] [Related]
8. Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders.
Loeffler DA; LeWitt PA; Juneau PL; Sima AA; Nguyen HU; DeMaggio AJ; Brickman CM; Brewer GJ; Dick RD; Troyer MD; Kanaley L
Brain Res; 1996 Nov; 738(2):265-74. PubMed ID: 8955522
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
Ferrer I; Blanco R; Carmona M; Puig B
J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
[TBL] [Abstract][Full Text] [Related]
10. Bcl-2 and Bax protein expression in Alzheimer's disease.
Tortosa A; López E; Ferrer I
Acta Neuropathol; 1998 Apr; 95(4):407-12. PubMed ID: 9560019
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer-type lesions in Huntington's disease.
Jellinger KA
J Neural Transm (Vienna); 1998; 105(8-9):787-99. PubMed ID: 9869319
[TBL] [Abstract][Full Text] [Related]
12. S100 beta protein expression in Alzheimer disease: potential role in the pathogenesis of neuritic plaques.
Sheng JG; Mrak RE; Griffin WS
J Neurosci Res; 1994 Nov; 39(4):398-404. PubMed ID: 7884819
[TBL] [Abstract][Full Text] [Related]
13. Fas and Fas-L expression in Huntington's disease and Parkinson's disease.
Ferrer I; Blanco R; Cutillas B; Ambrosio S
Neuropathol Appl Neurobiol; 2000 Oct; 26(5):424-33. PubMed ID: 11054182
[TBL] [Abstract][Full Text] [Related]
14. Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid.
Culvenor JG; McLean CA; Cutt S; Campbell BC; Maher F; Jäkälä P; Hartmann T; Beyreuther K; Masters CL; Li QX
Am J Pathol; 1999 Oct; 155(4):1173-81. PubMed ID: 10514400
[TBL] [Abstract][Full Text] [Related]
15. Neuregulin-1 and erbB4 immunoreactivity is associated with neuritic plaques in Alzheimer disease brain and in a transgenic model of Alzheimer disease.
Chaudhury AR; Gerecke KM; Wyss JM; Morgan DG; Gordon MN; Carroll SL
J Neuropathol Exp Neurol; 2003 Jan; 62(1):42-54. PubMed ID: 12528817
[TBL] [Abstract][Full Text] [Related]
16. Dementia, gliosis and expression of the small heat shock proteins hsp27 and alpha B-crystallin in Parkinson's disease.
Renkawek K; Stege GJ; Bosman GJ
Neuroreport; 1999 Aug; 10(11):2273-6. PubMed ID: 10439447
[TBL] [Abstract][Full Text] [Related]
17. Neuronal hemoglobin is reduced in Alzheimer's disease, argyrophilic grain disease, Parkinson's disease, and dementia with Lewy bodies.
Ferrer I; Gómez A; Carmona M; Huesa G; Porta S; Riera-Codina M; Biagioli M; Gustincich S; Aso E
J Alzheimers Dis; 2011; 23(3):537-50. PubMed ID: 21157025
[TBL] [Abstract][Full Text] [Related]
18. High selective expression of alpha7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritic plaques.
Yu WF; Guan ZZ; Bogdanovic N; Nordberg A
Exp Neurol; 2005 Mar; 192(1):215-25. PubMed ID: 15698636
[TBL] [Abstract][Full Text] [Related]
19. DNA fragmentation, gliosis and histological hallmarks of Alzheimer's disease.
Overmyer M; Kraszpulski M; Helisalmi S; Soininen H; Alafuzoff I
Acta Neuropathol; 2000 Dec; 100(6):681-7. PubMed ID: 11078220
[TBL] [Abstract][Full Text] [Related]
20. Plaque biogenesis in brain aging and Alzheimer's disease. I. Progressive changes in phosphorylation states of paired helical filaments and neurofilaments.
Su JH; Cummings BJ; Cotman CW
Brain Res; 1996 Nov; 739(1-2):79-87. PubMed ID: 8955927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
